Statistics for A Phase II Study Assessing the Safety and Efficacy of ASP1650 in Male Patients with Relapsed Refractory Germ Cell Tumors
Total visits
views | |
---|---|
A Phase II Study Assessing the Safety and Efficacy of ASP1650 in Male Patients with Relapsed Refractory Germ Cell Tumors | 3 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 2 |
June 2024 | 1 |
July 2024 | 0 |
Top country views
views | |
---|---|
United States | 3 |
Top city views
views | |
---|---|
Indianapolis | 2 |
Columbus | 1 |